Medications for Dermatitis Atopic

52 results
  • adbry

    (tralokinumab-ldrm)
    LEO Pharma Inc.
    ADBRY is indicated for treating moderate-to-severe atopic dermatitis in adults and pediatric patients aged 12 and older when topical therapies are insufficient or inappropriate. It can be used alone or in conjunction with topical corticosteroids.
  • cibinqo

    (abrocitinib)
    U.S. Pharmaceuticals
    CIBINQO is indicated for treating refractory, moderate-to-severe atopic dermatitis in adults and patients aged 12 and older, when the condition is not adequately managed by other systemic therapies or when those treatments are unsuitable. Co-use with other JAK inhibitors or biologics is not recommended.
  • cibinqo

    (abrocitinib)
    Pfizer Laboratories Div Pfizer Inc
    CIBINQO is indicated for treating adults and pediatric patients aged 12 and older with refractory, moderate-to-severe atopic dermatitis not adequately controlled by other systemic treatments, including biologics, or when those therapies are inadvisable. It is not recommended for use with other JAK inhibitors or immunosuppressants.
  • depo-medrol

    (methylprednisolone acetate)
    Pharmacia & Upjohn Company LLC
    DEPO-MEDROL is indicated for various conditions, including severe allergic reactions, dermatologic diseases, endocrine and gastrointestinal disorders, hematologic issues, and certain rheumatic diseases. It is also used for cerebral edema, palliative care in neoplastic diseases, and localized therapies in dermatologic conditions via intralesional or intra-articular administration.
  • desonide

    (Desonide)
    Cintex Services, LLC
    Desonide Gel, 0.05% is indicated for treating mild to moderate atopic dermatitis in patients aged 3 months and older. It should be used for the shortest duration necessary to achieve results, not exceeding 4 consecutive weeks, due to potential HPA axis suppression.
  • dexamethasone

    (Dexamethasone)
    Prasco Laboratories
    The drug is indicated for severe allergies, dermatologic and endocrine disorders, gastrointestinal and hematologic diseases, neurogenic conditions, neoplastic diseases, and various conditions across respiratory, ophthalmic, renal, and rheumatic diseases. It serves to manage symptoms or provide palliative care in specific cases.
  • dexamethasone

    (dexamethasone)
    Amneal Pharmaceuticals NY LLC
    This drug is indicated for severe allergic conditions, dermatologic and endocrine disorders, gastrointestinal issues, hematologic disorders, certain cancers, acute nervous system conditions, ocular inflammation, renal diseases, respiratory conditions, and as adjunctive therapy for rheumatic disorders. It addresses various severe and chronic health issues unresponsive to standard treatments.
  • dexamethasone

    (Dexamethasone)
    Rising Pharma Holdings, Inc.
    This drug is indicated for various conditions, including endocrine and rheumatic disorders, collagen diseases, severe allergic states, ophthalmic and respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, gastrointestinal diseases, and certain miscellaneous conditions, as well as for diagnostic testing of adrenocortical hyperfunction.
  • dexamethasone sodium phosphate

    (Dexamethasone Sodium Phosphate)
    Fresenius Kabi USA, LLC
    This drug is indicated for various conditions requiring intravenous or intramuscular administration, including endocrine disorders, rheumatic diseases, dermatologic issues, severe allergic reactions, and certain gastrointestinal and respiratory diseases. It also addresses hematologic, neoplastic, and neurologic disorders, as well as promoting healing in soft tissue and joint conditions.
  • dexamethasone sodium phosphate

    (DEXAMETHASONE SODIUM PHOSPHATE)
    Fresenius Kabi USA, LLC
    The drug is indicated for conditions requiring intravenous, intramuscular, intra-articular, or intralesional administration. It treats endocrine disorders, rheumatic and collagen diseases, severe allergic states, dermatologic issues, various gastrointestinal and respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, and certain nervous system conditions.